Unknown

Dataset Information

0

Efficacy and safety of supramaximal titrated inhibition of renin-angiotensin-aldosterone system in idiopathic dilated cardiomyopathy.


ABSTRACT: AIMS:The optimal dosing strategies for blocking the renin-angiotensin-aldosterone system in idiopathic dilated cardiomyopathy (IDCM) are poorly known. We sought to determine the long-term efficacy and safety of supramaximal titration of benazepril and valsartan in patients with IDCM. METHODS AND RESULTS:480 patients with IDCM in New York Heart Association functional class II-IV and with left ventricular ejection fraction ?35% were randomly assigned to extended-release metoprolol (mean 152?mg/day, range 23.75-190), low-dose benazepril (20?mg/day), low-dose valsartan (160?mg/day), high-dose benazepril (mean 69?mg/day, range 40-80), and high-dose valsartan (mean 526?mg/day, range 320-640). After a median follow-up of 4.2?years, high-dose benazepril and valsartan, compared with their respective low dosages, resulted in 41% and 52% risk reduction in the primary endpoint of all-cause death or admission for heart failure (P?=?0.042 and 0.002), promoted functional improvement, and reversed remodelling as assessed by New York Heart Association classes, quality-of-life scores, and echocardiographic recording of left ventricular ejection fraction, left ventricular end-diastolic volume, mitral regurgitation, and wall motion score index. Compared with metoprolol, high-dose valsartan reduced risk for the primary endpoint by 46% (P?=?0.006), whereas high-dose benazepril and both low-dose groups showed no significant difference. Major adverse events involved hypotension and renal impairment but were largely tolerated. CONCLUSIONS:Supramaximal doses of benazepril and valsartan were well tolerated and produced extra benefit than their low dosages in clinical outcome and cardiac reverse remodelling in patients with IDCM and modest-severe heart failure. ClinicalTrials.gov identifier: NCT01917149.

SUBMITTER: He Z 

PROVIDER: S-EPMC5746969 | biostudies-literature | 2015 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Efficacy and safety of supramaximal titrated inhibition of renin-angiotensin-aldosterone system in idiopathic dilated cardiomyopathy.

He Zheng Z   Sun Yun Y   Gao Hui H   Zhang Jun J   Lu Yuhong Y   Feng Jihua J   Su Hongli H   Zeng Chao C   Lv Anlin A   Cheng Kang K   Li Yan Y   Li Huan H   Luan Ronghua R   Wang Ling L   Yu Qiujun Q  

ESC heart failure 20150714 4


<h4>Aims</h4>The optimal dosing strategies for blocking the renin-angiotensin-aldosterone system in idiopathic dilated cardiomyopathy (IDCM) are poorly known. We sought to determine the long-term efficacy and safety of supramaximal titration of benazepril and valsartan in patients with IDCM.<h4>Methods and results</h4>480 patients with IDCM in New York Heart Association functional class II-IV and with left ventricular ejection fraction ≤35% were randomly assigned to extended-release metoprolol (  ...[more]

Similar Datasets

| S-EPMC8237039 | biostudies-literature
| S-EPMC3449069 | biostudies-literature
| S-EPMC7172808 | biostudies-literature
| S-EPMC9206216 | biostudies-literature
| S-EPMC6430926 | biostudies-literature
| S-EPMC3354321 | biostudies-literature
| S-EPMC2600881 | biostudies-literature
| S-EPMC5118476 | biostudies-literature
| S-EPMC5758757 | biostudies-literature
| S-EPMC6051425 | biostudies-literature